New safety standards for anticoagulant therapy in the treatment of atrial fibrillation por E. I. Baranova

Obter o texto integral

The Study of Growing Companies as a New Tool of Microeconomic Analysis por E. I. Baranova

Obter o texto integral

Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations por E. I. Baranova, Zhanna Kobalava

Obter o texto integral

Central directions for reducing cardiovascular mortality: what can be changed today? por E. V. Shlyakhto, E. I. Baranova

Obter o texto integral

SENTINEL SYSTEM – electronic system for collecting real-world data por E. O. Eremenko, M. I. Baranova

Obter o texto integral

Antigipertenzivnaya terapiya i risk razvitiya sakharnogo diabeta por E I Baranova, O O Bol'shakova

Obter o texto integral

Approaches to resolve practical challenges in the context of assessing the price of biosimilar products por A. H.-M. Valeeva, M. I. Baranova

Obter o texto integral

Drug utilization research at the individual level as the main concept of pharmacoepidemiology por S. M. Mukhina, M. I. Baranova, Yu. M. Gomon

Obter o texto integral

STUDIES ON THE ROLE OF CYTOKINES POLYMORPHISM IN PATHOGENESIS OF CHRONIC URTICARIA por N. I. Baranova, O. A. Levashova, S. V. Kozhenkova

Obter o texto integral

HARPER — protocol template for real-world trials for evaluating treatment efficacy por S. M. Mukhina, M. I. Baranova, Yu. E. Balykina

Obter o texto integral

Problems and potential solutions to drug shortages por I. R. Svechkareva, D. E. Shilova, M. I. Baranova

Obter o texto integral

HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION? por E. I. Baranova, А. G. Filatova, V. A. Ionin

Obter o texto integral

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution? por E V Schlyakhto, E I Baranova, V A Ionin

Obter o texto integral

Humoral and cellular immunity parameters in children with allergic diseases after COVID-19 por N.I. Baranova, L.A. Ashchina, A.I. Kozina

Biomarkers of fibrosis and inflammation and the risk of arrhythmia recurrence after elective electrical cardioversion in patients with atrial fibrillation and metabolic syndrome por E. I. Barashkova, V. A. Ionin, E. I. Baranova

Obter o texto integral

Hypertension in peri- and postmenopausal women — pathophysiological mechanisms and approaches to treatment por E. I. Baranova, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva

Obter o texto integral

Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions por V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto

Obter o texto integral

A clinical case of extremely severe COVID-19 with a favourable outcome por A. I. Bolgova, L. A. Aschina, N. I. Baranova, O. N. Lesina

Obter o texto integral

Factors associated with inappropriate reduced doses of non-vita-min K antagonist oral anticoagulants in patients with atrial fibrillation por V. A. Ionin, O. I. Bliznuk, V. A. Pavlova, E. I. Baranova

Obter o texto integral

The role of neutrophils in the pathogenesis of COVID-19 (literature review) por Lyudmila A. Aschina, Nadezhda I. Baranova, Nadezhda I. Mikulyak, Denis I. Zhuravlev